Oxford Asset Management »

Neumora Therapeutics shares owned by Oxford Asset Management

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Oxford Asset Management from 13F filings

Historical chart of Oxford Asset Management investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Oxford Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Oxford Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $138k 10k 13.75

More positions owned by Oxford Asset Management

Stellantis SHS (STLA)
Draftkings Com Cl A (DKNG)
Cannae Holdings (CNNE)
Geopark Usd Shs (GPRK)
Philip Morris International (PM)
Adobe Systems Incorporated (ADBE)
Overseas Shipholding Group I Cl A New (OSG)
Zoetis Cl A (ZTS)
Snap Cl A (SNAP)
Alphabet Cap Stk Cl A (GOOGL)
R1 RCM (RCM)
Medical Properties Trust Call Option (MPW)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Archer Daniels Midland Company (ADM)
Cooper Cos (COO)

View all positions for Oxford Asset Management

Top funds holding Neumora Therapeutics

Softbank Group Corp
FMR
MIC Capital Management UK
T. Rowe Price Investment Management
ICONIQ Capital
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Artal Group
EcoR1 Capital
Johnson & Johnson
Citadel Advisors
Avidity Partners Management
Hillhouse Capital Advisors
OrbiMed Advisors
BlackRock
Soros Capital Management

View all funds holding Neumora Therapeutics